Day: March 27, 2021
-
FDA Approves New indication for Drug to Treat Neurogenic Detrusor Overactivity in Pediatric Patients
Today, the U.S. Food and Drug Administration approved a new indication for Myrbetriq (mirabegron extended-release tablets) and Myrbetriq Granules (mirabegron for extended-release oral suspension) to treat neurogenic detrusor overactivity (NDO), a bladder dysfunction related to neurological impairment, in children ages three years and older. Myrbetriq is also indicated for overactive bladder in adult patients. “Today’s…
-
Innovative Propulsion System Gets Ready to Help Study Moon Orbit for Artemis
In 2021, NASA’s Cislunar Autonomous Positioning System Technology Operations and Navigation Experiment, or CAPSTONE, CubeSat will launch to a never-before-used cislunar orbit near the Moon. As a pathfinder for Gateway, a Moon-orbiting outpost that is part of NASA’s Artemis program, CAPSTONE will help reduce the risk for future spacecraft by verifying the dynamics of a unique halo-shaped orbit.…
-
NASA Provides $45M Boost to US Small Businesses
Small businesses are vital to NASA’s mission, helping expand humanity’s presence in space and improve life on Earth. NASA has selected 365 U.S. small business proposals for initial funding from the agency’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) program, a total investment of more than $45 million. “At NASA,…